Europska Unija - hrvatski - EMA (European Medicines Agency)

glaxosmithkline biologicals sa - recombinant varicella zoster virus glycoprotein e - herpes zoster - cjepiva - shingrix is indicated for prevention of herpes zoster (hz) and post-herpetic neuralgia (phn), in:adults 50 years of age or older;adults 18 years of age or older at increased risk of hz. korištenje shingrix moraju biti u skladu sa službenim preporukama.

Europska Unija - hrvatski - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a.  - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - infekcije respiratornih sincicijskih virusa - cjepiva - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. korištenje ovog cjepiva mora se provoditi u skladu sa službenim preporukama.

Europska Unija - hrvatski - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - piletina - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

Europska Unija - hrvatski - EMA (European Medicines Agency)

intervet international b.v. - cellular " potpomognuta živa рекомбинантная turske герпесвирус (soj hvp360), izražavajući sintezu proteina virusa nd i vp2 s proteinima virusa ИБД - ptica virus herpesa (bolest Марека) + ptičji virus infektivne бурсальной bolesti (bolest Гамборо) + virusa ньюкаслской bolesti/парамиксовируса - chicken; embryonated chicken eggs - for active immunisation of one-day-old chicks or 18-19-day-old embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to prevent mortality and to reduce clinical signs and lesions caused by infectious bursal disease (ibd) virus,to reduce mortality, clinical signs and lesions caused by marek’s disease (md) virus.

Europska Unija - hrvatski - EMA (European Medicines Agency)

pfizer europe ma eeig - respiratory syncytial virus, subgroup a, stabilized prefusion f protein / respiratory syncytial virus, subgroup b, stabilized prefusion f protein - infekcije respiratornih sincicijskih virusa - cjepiva - abrysvo is indicated for:passive protection against lower respiratory tract disease caused by respiratory syncytial virus (rsv) in infants from birth through 6 months of age following maternal immunisation during pregnancy. pogledajte odjeljke 4. 2 i 5. active immunisation of individuals 60 years of age and older for the prevention of lower respiratory tract disease caused by rsv. korištenje ovog cjepiva mora se provoditi u skladu sa službenim preporukama.

Europska Unija - hrvatski - EMA (European Medicines Agency)

intervet international b.v. - Živi rekombinantni herpesvirus purine herpesvirusa (soj hvt / ilt-138), koji eksprimira glikoproteine ​​gd i gi infektivnog laringotraheitisa - imunomodulatori za aves živih virusnih cjepiva - piletina - za aktivne imunizacije jednodnevnih pilića, da se smanji smrtnost, klinički znakovi i promjene izazvane virusom ptičje infektivni ларинготрахеита (ИЛТ) i virus Марека bolest (md) virus.

Europska Unija - hrvatski - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - imunološki za aves - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Europska Unija - hrvatski - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease (md) virus, serotype 1, strain rn1250 - imunološki za aves - piletina - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus).

Europska Unija - hrvatski - EMA (European Medicines Agency)

merck sharp dohme ltd - tip papilloma virus 6 Л1 sirutke papilloma virus tipa 11 Л1 sirutke papilloma virus tipa 16 Л1 sirutke papilloma virus tipa 18 Л1 proteina - papillomavirus infections; uterine cervical dysplasia; condylomata acuminata; immunization - cjepiva - Силгард cjepivo za korištenje u dobi od 9 godina za upozorenje:prekanceroznih lezija genitalnih organa (vrata maternice, vulve i vagine), prekanceroznih lezija analnom području, raka grlića materice i analnog raka, uzročno povezane s određenim онкогенным virusom hpv čovjeka (hpv); genitalne bradavice (acuminata acuminata), uzročno povezane s određenim hpv-a. pogledajte odjeljke 4. 4 i 5. 1 za važne informacije o podacima koji podržavaju ovu oznaku. korištenje Силгард moraju biti u skladu sa službenim preporukama.

Europska Unija - hrvatski - EMA (European Medicines Agency)

sanofi pasteur - influenza a virus subtype h1n1 haemagglutinin, recombinant, influenza a virus subtype h3n2 haemagglutinin, recombinant, influenza b virus victoria lineage haemagglutinin, recombinant, influenza b virus yamagata lineage haemagglutinin, recombinant - gripa, ljudska - cjepiva - supemtek is indicated for active immunization for the prevention of influenza disease in adults. supemtek should be used in accordance with official recommendations.